Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jun;79(6):734-736.
doi: 10.1136/annrheumdis-2020-217480. Epub 2020 Apr 15.

Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist

Affiliations
Comment

Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist

Elizabeth R Graef et al. Ann Rheum Dis. 2020 Jun.
No abstract available

Keywords: antirheumatic agents; health services research; hydroxychloroquine.

PubMed Disclaimer

Conflict of interest statement

Competing interests: FB reports personal fees from Boehringer, Bone Therapeutics, Expanscience, Galapagos, Gilead, GSK, Merck Sereno, MSD, Nordic, Novartis, Pfizer, Regulaxis, Roche, Sandoz, Sanofi, Servier, UCB, Peptinov, TRB Chemedica and 4P Pharma. RG reports personal fees from Pfizer, Cornerstones, Jannsen and Novartis. PK reports personal fees from GlaxoSmithKline, Sanofi-Aventis, Pfizer, Abbvie, Novartis Pharma, Eli Lilly and Bristol-Myers Squibb. AHJK reports grants from NIH (National Institutes of Health)/NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and Rheumatology Research Foundation and personal fees from Exagen Diagnostics and GlaxoSmithKline. JAS reports grants from NIH/NIAID (National Institute of Allergy and Infectious Diseases)/Autoimmune Centers of Excellence, the Rheumatology Research Foundation, the Brigham Research Institute and the R. Bruce and Joan M. Mickey Research Scholar Fund as well as personal fees from Bristol-Myers Squibb, Gilead, Inova, Janssen and Optum.

Comment in

Comment on

References

    1. Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html. (accessed 31 March 2020).
    1. Request for Emergency Use Authorization For Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied From the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease. https://www.fda.gov/media/136534/download. (accessed 30 March 2020).
    1. Advisory on the use of hydroxychloroquine as prophylaxis for SARS-CoV-2 infection. https://www.mohfw.gov.in/pdf/AdvisoryontheuseofHydroxychloroquinasprophy.... (accessed 31 March 2020).
    1. Décret n° 2020–314 du 25 mars 2020 complétant le décret n° 2020–293 du 23 mars 2020 prescrivant les mesures générales nécessaires pour faire face à l’épidémie de covid-19 dans le cadre de l’état d’urgence sanitaire. https://www.legifrance.gouv.fr/eli/decret/2020/3/25/SSAZ2008362D/jo/texte. (accessed 30 March 2020).
    1. Texas State Board of Pharmacy. https://www.pharmacy.texas.gov/files_pdf/291.30.pdf. (accessed 30 March 2020).